FEATURED/ARCHIVES (26/05/24)
×
Variation of Subclinical Psychosis Across 16 Sites in Europe and Brazil: Findings from the Multi-National EU-GEI Study · January 2024
Articles
Psychological Medicine
×
Predictors of Internalized Stigma in Patients with Schizophrenia in Northern Chile: A Longitudinal Study · November 2022
Articles
Healthcare
×
A Pilot 1-Year Follow-Up Randomised Controlled Trial Comparing Metacognitive Training to Psychoeducation in Schizophrenia: Effects on Insight · January 2023
Articles
Schizophrenia
×
Symptomatic and Functional Outcomes After Treatment with Paliperidone Palmitate 3-Month Formulation for 52 Weeks in Patients with Clinically Stable Schizophrenia · May 2020
Articles
Therapeutic Advances in Psychopharmacology
×
Clinical Predictors of Antipsychotic Treatment Resistance: Development and Internal Validation of a Prognostic Prediction Model by the STRATA-G Consortium · October 2022
Articles
Schizophrenia Research
×
First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores than Others: A Cluster Analysis of EU-GEI Data · August 2022
Articles
Schizophrenia Bulletin
×
Gene Expression and Response Prediction to Amisulpride in the OPTiMiSE First Episode Psychoses · May 2020
Articles
NCBI>Neuropsychopharmacology
×
Mortality in People with Schizophrenia: A Systematic Review and Meta-Analysis of Relative Risk and Aggravating or Attenuating Factors · May 2022
Articles
World Psychiatry
×
Impact of the COVID-19 Pandemic on Non-COVID-19 Hospital Mortality in Patients with Schizophrenia: A Nationwide Population-Based Cohort Study · October 2022
Articles
Molecular Psychiatry
×
Characteristics Associated with the Risk of Psychosis among Immigrants and Their Descendants in France · April 2021
Articles
Brain and Behavior
×
History of ECT in Schizophrenia: From Discovery to Current Use · August 2022
Articles
Schizophrenia Bulletin Open
×
Long-Term Effects of Roluperidone on Negative Symptoms of Schizophrenia · March 2023
Articles
Schizophrenia Research
×
Microbiota-Orientated Treatments for Major Depression and Schizophrenia · April 2020
Articles
Nutrients
×
Coping Profiles of Family Caregivers of People with Schizophrenia: Differentiations between Parent and Sibling Caregivers · December 2022
Articles
Journal of Mental Health
×
Antipsychotics and Risk of QT Prolongation: A Pharmacovigilance Study · December 2022
Abstracts
Psychopharmacology
×
Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment? · June 2021
Articles
International Journal of Molecular Sciences
×
Digital Behavioural Signatures Reveal Trans-Diagnostic Clusters of Schizophrenia and Alzheimer’s Disease Patients · October 2023
Articles
European Neuropsychopharmacology
×
Family Psychoeducation to Improve Outcome in Caregivers and Patients with Schizophrenia: A Randomized Clinical Trial · June 2023
Articles
Frontiers in Psychiatry
×
Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study · April 2023
Articles
Neuropsychiatric Disease and Treatment